Enhance Med Management Outcomes with Advanced Services

Omnicell’s Advanced Services, powered by a connected intelligent infrastructure, are enhancing business and clinical outcomes across inpatient to outpatient settings.

Latest News

Center for Innovative Medication Management

Omnicell and Long Island University have launched this immersive pharmacy technology and analytics lab, designed to provide pharmacy students hands-on experience with innovative medication management technology.


Achieving IV Outcomes

Learn how Omnicell’s full-service, subscription-based model has helped Allegheny Health Network achieve a clear, quick path to improved outcomes with no capital investment.

2023 ESG Report

Innovating for a Better Way

Omnicell’s 2023 ESG Report highlights our continued commitment to Environmental, Social, Governance, and Innovation initiatives and progress throughout 2022 toward our public goals and targets.


Inventory Optimization Service Introduction

Learn how health systems can improve medication management efficiency through advanced software, robust benchmarking, predictive and prescriptive analytics, and clinical experts to identify optimization opportunities.

Latest News

Pharmacy Robot Dispenses Orders at Christ Hospital

Cincinnati-based Christ Hospital introduced Omnicell’s XR2 robot in June to support inpatient medication dispensing, dispensing around 6,000 doses a day.


Facing the Looming Nursing Shortage Head-On

Prominent healthcare experts discuss how to limit the impact of nursing shortages through an intelligent infrastructure of technology and data intelligence.

More Resources

Explore a variety of informative materials to inspire your journey to an autonomous pharmacy

Case Study

Archbold Medical Center Achieves Medication Inventory Visibility and Optimization

Learn how better inventory insight helped Archbold to realize significant cost savings and improve other aspects of medication management.


Federal 340B Ruling Underscores Need for Balanced Pharmacy Program

A recent ruling by a Philadelphia federal appeals court could introduce more barriers to specialty drugs for health systems that don’t have an in-house specialty pharmacy.